Litcius/Paper detail

Hyaluronidase-trigger nanocarriers for targeted delivery of anti-liver cancer compound

Junxin Xu, Siling Chen, Jianmei Yang, Zhengquan Nie, Junnan He, Yong Zhao, Yong Zhao, Xiaoqing Liu, Jin Zhang, Yan Zhao, Yan Zhao

2023RSC Advances17 citationsDOIOpen Access PDF

Abstract

HA/(MI) 7 -β-CD NCs exhibits HA receptor-mediated targeting and disassembly properties under HAase stimulation, which was utilized to trap, targeted deliver and controlled release of anti-liver cancer compound CSL.

Topics & Concepts

NanocarriersLiver cancerCytotoxicityCancer cellChemistryDoxorubicinCD44Cancer researchPharmacologyDrug deliveryCancerChemotherapyMedicineCellBiochemistryIn vitroInternal medicineHepatocellular carcinomaOrganic chemistryGlycosylation and Glycoproteins ResearchNanoparticle-Based Drug DeliveryProteoglycans and glycosaminoglycans research
Hyaluronidase-trigger nanocarriers for targeted delivery of anti-liver cancer compound | Litcius